The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Pleased to see everything has passed today and we are all systems go. I am by no means an informed punter on this and am just in for a bit of fun.
General question about this share itself, looking at the number of trades recently, do we feel that we are a bit of an under the radar way in to H1, obviously we know about it but how does 25 trades on the day this has been formalised equate to the type of opportunity and demand that we are expecting next week?
Not trying to ramp or deramp as the share price really doesn't matter at all right now with the preset conversion rate, just interested in when we think mainstream market demand will kick in for H1...
Yeah I think we are all in a situation of expecting nothing, anything at all would be a nice boost. At least they are incentivised to come up with an RTO so there's something in it for then getting it over the line.
Over time I've started enjoying ScottDavids Advfn rants, it's just kinda therapeutic in a way that someone is still talking about them.
Maybe we will get a Thanksgiving Day miracle, I certainly need it after how hard Synairgen has been beaten down recently!
I've just jumped back in so feel free to fire up the RNS machine, he does seem to like a mid session release as well so could be any time.
Assume AZ still has his options wager on share price being over 0.68 by the end of the year?
I understand that this is a stressful time and the share price hasn't moved how we wanted but I think people just need to take a moment and appreciate what we've achieved to date and the enormous potential ahead of us.
Phase 2&3 trials fully funded and to be delivered within a year
Absolutely glowing results from phase 2 backed up by Lancet peer review
20 country P3 trial and international recognition for the potential applications of SNG
All against the backdrop of heading into a second wave of Covid which is shutting down world economies.
Yes some vaccines posted early promising results but the idea of abandoning everything we've achieved to date to focus back on COPD is just bonkers don't you think. The only way it would make sense is if data subsequent to P2 showed no real effect on Covid and there hasn't been the slightest hint of that.
Just had the corporate action event come up on AJ Bell, the link to the resolutions doesn't work and says must reply by 17th November. Assume I'm voting for everything...
Also consider the obviously coordinated press coverage, very USA focused wouldn't you say from the links I've seen so far...
Think they said she was from moneyweek, maybe she's invested too haha
Tantalisingly close to a direct question time mention!
The mail is a campaign to let people kill their elderly relatives at Christmas
Just had corporate action note pop up in my AJ Bell account relating to AOGL but no message loads...
Guys I called it, big rise set for tomorrow.
For those questioning whether this is a rehash... Read this one para from the mail article.
A drug that coronavirus patients inhale slashes their risk of falling seriously ill and speeds up recovery, a major study has revealed in the second Covid breakthrough this week.
Two things to note, in the opinion of the author:-
This is a MAJOR study
Second Covid breakthrough
So they are saying it's very important and contextually in the same ballpark as the Pfizer news.
Interesting to see the front pages of the papers tonight
I'm torn but that does sound a little desparate, there's nothing SNG have done to warrant such a drop so why should they have to make an announcement. I'd prefer the next RNS to be substantive news which takes us through the price ceiling
As an incomplete thought I've often wondered if one of our selling points will be around the price of a treatment. I see it as one of our key strengths with sunken costs and low overheads, we could come up with a price impossible to ignore that generates the profits by volume.
We've approximated that Remdesivir is £1400 per treatment, what if we could push out a more effective treatment at half the price. With cost being a major consideration in EUA type discussions this could really be a silver bullet against big pharma.
If we did that then why would anyone even consider an alternative that wasn't SNG?
My company makes a product that limits the vehicles ability to turn on until a breath test has been successfully taken to prove the driver isn't intoxicated or under the influence. How long do you think it has before this function is made meaningless by all the SEE developments?
I've LinkedIn with some of the expert voices already and I'm on Shreys telegram too, my backup plan is semi sorted!
Funny how we have one of the biggest price rise days in years based on absolutely nothing and still only just over 100 posts on LSE. We must be so far under the radar of many but hopefully for not much longer now...
I've said it before though and today kinda reiterates it to me, people who are aware of SEE and didn't invest see us as an 'invest tomorrow' type stock so when they start to see signs of that day actually arriving this could go exponential.
Just my random Friday ramp long to be forgotten by monday
I hope to look back on this post with nostalgia when we are over 200p
Allow me to jump in with...
-Seems the yanks woke up
- I wouldn't want to be out of this over a weekend
Looking on the Lancet website, it says the following about time to publish after acceptance:-
Swift+ and Fast-track publication
We understand the pressure authors face to have their voices heard first, and we are committed to publishing important papers fast. All randomised controlled trials are eligible for Swift+, our fastest route to publication. Our editors will provide a decision within 10 working days; if sent for review this will include full peer review. If accepted, publication online will occur within another 10 working days (10+10).
So if Tom Wilkinson was notified that it was accepted last Friday on the day of his lecture where we first head it was accepted then ten additional working days would be that would be an unlucky some Friday 13th November deadline date for publishing.
Based on the mention that they normally publish online on Thursdays that would mean that Thursday 12th sounds like the most likely release date based on the house of cards i've built this assumption on...
What time roughly was Blair on R4 this morning please, I'd like to listen in